Vaccines for Children (VFC) FY26
Health and Human Services, Department of · CENTERS FOR DISEASE CONTROL AND PREVENTION
This notice is not accepting responses (deadline was Jan 7, 2026, 1:00 PM EST).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Jan 7, 2026, 1:00 PM EST
- Posted
- Dec 17, 2025
- Solicitation
- 000HCJBC-2025-95504
- Set-aside
- No Set aside used
- Place of performance
- Atlanta, GA, USA
- Contracting office
- CDC OFFICE OF ACQUISITION SERVICES · ATLANTA · GA
- Source
- SAM.gov · updated Jul 5, 2026
Description
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$36,321
Middle of the pack for similar past awards
Most similar awards fall between $8,499 and $203,138
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MCKESSON CORPORATION2023 awards$11.98B
- 2BAVARIAN NORDIC A/S1 award$1.17B
- 3EMERGENT BIOSOLUTIONS CANADA INC2 awards$624.99M
- 4CHARTWELL RX LLC3 awards$254.44M
- 5ALVOGEN, INC.1 award$227.68M
- 6MERCK SHARP & DOHME LLC31 awards$157.47M
- 7GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$130.32M
- 8ELUSYS THERAPEUTICS INC1 award$124.52M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID ed5b34cdd1424a35817f9f3a9bb20fd2.